Summary
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the State Street Health Care Select Sector SPDR ETF ETF (XLV), a passively managed exchange traded fund launched on December 16, 1998.
Healthcare Is Rising: XLV Is A Better Option For Investors Than BME
BlackRock Health Sciences Trust (BME) has recently outperformed due to a narrowing NAV discount, not superior portfolio management. XLV, the passive healthcare ETF, has consistently delivered higher total returns and better NAV preservation than BME over 5- and 10-year periods. BME's recent strategy shift away from call options to capital gains distributions has not produced positive alpha relative to XLV.
Healthcare ETFs Are Looking Up: Here's Why
Healthcare ETFs are hitting 52-week highs as earnings improve, dealmaking accelerates, FDA approvals stay strong and investors seek defensive growth.
Health Care Select Sector SPDR Fund Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 9,200 | $1.36M | $1.49M | $129,541.3 | 9.55% |
| DI David Izzi Brown, LISLE/CUMMINGS Inc. | 1,919 | $254,141.41 | $311,933.45 | $57,792.04 | 22.74% |
 Michelle S. Hickox FIRST FINANCIAL BANKSHARES Inc. | 1,688 | $234,919 | $284,326.72 | $49,407.72 | 21.03% |
 Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 2,988 | $406,189.85 | $485,699.4 | $79,509.55 | 19.57% |
 Curtis Ellergodt Rothschild Investment LLC | 1,134 | $158,618.32 | $185,460.03 | $26,841.71 | 16.92% |
Health Care Select Sector SPDR Fund (XLV) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Health Care Select Sector SPDR Fund ever had a stock split?
Health Care Select Sector SPDR Fund Profile
| ARCA Exchange | US Country |
Overview
The fund outlined seeks to mirror the performance of a specific index focused on the healthcare sector. It adopts a replication strategy, investing primarily in the stocks that form part of the index it tracks. This approach ensures that the fund's performance closely aligns with that of the index. The covered industries within this index encompass a broad range of companies involved in pharmaceuticals, health care equipment and supplies, health care providers and services, biotechnology, life sciences tools and services, and health care technology. By focusing on these areas, the fund positions itself within an essential and often rapidly evolving segment of the economy. The fund is characterized by its non-diversified status, meaning it might invest more heavily in specific securities than a diversified fund would, potentially increasing its risk and return profile.
Products and Services
- Pharmaceuticals:
- Health Care Equipment & Supplies:
- Health Care Providers & Services:
- Biotechnology:
- Life Sciences Tools & Services:
- Health Care Technology:
This includes companies involved in the research, development, manufacturing, and marketing of medicines and drugs. Pharmaceuticals are vital for treating and preventing diseases, making this sector a crucial part of the healthcare industry and a significant component of the index the fund tracks.
This category comprises businesses that produce medical equipment, surgical supplies, and healthcare products. These are indispensable tools in diagnostics, treatment, and patient care, contributing to the advancement of the healthcare field and forming another vital segment of the index.
Companies falling into this sector offer medical services directly to patients. This can include hospitals, nursing homes, diagnostics laboratories, and outpatient care centers. Their inclusion in the index indicates the fund's investment in firms directly involved in delivering healthcare services to the public.
This area focuses on companies that utilize biological processes for medical research, development, and production. Biotechnology is at the forefront of developing innovative therapies and drugs, often using living organisms or molecular biology techniques. It plays a significant role in the healthcare sector by contributing to new medical breakthroughs, reflected in the index composition.
It covers enterprises providing products and services essential for scientific research, including the development of drug discovery and diagnostics solutions. This segment supports the healthcare industry's broader ecosystem by enabling the research and development activities fundamental to innovation.
This last sector includes companies that apply technology to enhance healthcare delivery and efficiency. Health care technology innovations range from electronic health records and telemedicine to wearable medical devices and health information systems, signaling the increasing role of technology in improving healthcare outcomes.
